FIELD: medicine, pharmacology. SUBSTANCE: invention proposes cyclohexapeptide for treatment as drug of the following structural formula: cyclo-lysyl-histidyl-glycyl-lysyl-histidyl-glycine. Drug has glycine as stabilizing agent (vehicle) additionally. Drug shows high effectiveness of effect with respect to stimulation of humoral immunity, immune response potency and molecules of intercellular interaction in therapy of immunodeficiency states. EFFECT: enhanced effectiveness of agent. 3 cl, 2 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR TREATMENT OF PATIENTS WITH IMMUNODEFICIENCY STATE | 1999 |
|
RU2157234C1 |
| PREPARATION FOR OVERCOMING MULTIDRUG RESISTANCE | 2008 |
|
RU2434879C2 |
| AGENT STIMULATING ANTIGEN-NONDEPENDING DIFFERENTIATION OF LYMPHOCYTE B | 2000 |
|
RU2166956C1 |
| PREPARATION FOR TREATING INFLAMMATORY DISEASES | 2000 |
|
RU2170101C1 |
| METHOD OF PREVENTION AND CORRECTION OF TOXIC IMMUNE ALTERATIONS | 2007 |
|
RU2364396C2 |
| AGENT FOR COPING WITH STEROID RESISTANCE | 2009 |
|
RU2404792C1 |
| METHOD FOR PREPARING AUTOLOGOUS TUBERCULOSIS VACCINE | 2008 |
|
RU2372936C1 |
| METHOD FOR EVALUATING FUNCTIONAL STATE OF IMMUNITY SYSTEM IN PATIENTS CEREBRAL INJURIES | 2001 |
|
RU2184969C1 |
| METHOD OF TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2006 |
|
RU2323728C2 |
| PHARMACEUTICAL INJECTION COMPOSITION ON BASIS OF TILORONE FOR TREATMENT OF PURULENT-DESTRUCTIVE PROCESSES WITH SIGNS OF IMMUNE INSUFFICIENCY | 2007 |
|
RU2359664C1 |
